CisplatinAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCombined Modality TherapyLung NeoplasmsTreatment OutcomeOvarian NeoplasmsBreast NeoplasmsSurvival AnalysisDrug Resistance, NeoplasmDoxorubicinDisease-Free SurvivalCyclophosphamideEtoposideDrug Administration ScheduleSurvival RateNeoplasm StagingPaclitaxelPrognosisNeoplasmsDeoxycytidineCarcinoma, Non-Small-Cell LungVinblastineStomach NeoplasmsCarboplatinCell Line, TumorPlatinumNeoplasm MetastasisNeoplasm Recurrence, LocalTaxoidsNeoadjuvant TherapyEarly Detection of CancerCarcinoma, Squamous CellFollow-Up StudiesIfosfamideAdenocarcinomaMethotrexateAntineoplastic Agents, PhytogenicAntimetabolites, AntineoplasticHead and Neck NeoplasmsDose-Response Relationship, DrugColonic NeoplasmsTesticular NeoplasmsVomitingCarcinomaMice, NudeProspective StudiesGene Expression Regulation, NeoplasticBleomycinProstatic NeoplasmsApoptosisInduction ChemotherapyPancreatic NeoplasmsDisease ProgressionDrug Screening Assays, AntitumorColorectal NeoplasmsNauseaCamptothecinNeutropeniaInfusions, IntravenousNeoplasm InvasivenessFluorouracilTumor Markers, BiologicalCell SurvivalKaplan-Meier EstimateRadiotherapy, AdjuvantRadiotherapyMitomycinTime FactorsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsTumor Cells, CulturedAntineoplastic Agents, AlkylatingEsophageal NeoplasmsXenograft Model Antitumor AssaysClinical Trials as TopicLiver NeoplasmsOrganoplatinum CompoundsBone NeoplasmsDrug SynergismAntibodies, MonoclonalNeoplasm ProteinsDNA AdductsSalvage TherapyNeoplasms, Germ Cell and EmbryonalLeukopeniaTegafurAnthracyclinesAntibiotics, AntineoplasticTumor Suppressor Protein p53Radiotherapy DosageReceptor, erbB-2Peritoneal NeoplasmsReverse Transcriptase Polymerase Chain ReactionReceptors, EstrogenCancer VaccinesOxonic AcidAntibodies, Monoclonal, HumanizedChemotherapy, Cancer, Regional Perfusion